David L DeRemer

10PUBLICATIONS
35CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsCancer geneticsPacific Peoples social determinants of healthPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Jun 19, 2025
Racial Disparities in Analgesic and Psychiatric Medication Use During End-Of-Life Care in Advanced-Stage Colorectal Cancer: A Retrospective Cohort Study.

John M Allen, Olga M Trejos Kweyete, Yi Guo

|May 28, 2025
Zolbetuximab-clzb: Targeting Claudin 18.2 in Advanced Gastric and Gastroesophageal Adenocarcinoma.

Gabrielle L Gorwitz, David L DeRemer

|Jul 24, 2024
Implementation of a pharmacogenetic panel-based test for pharmacotherapy-based supportive care in an adult oncology clinic.

Emily J Cicali, Elizabeth Eddy, Yan Gong

|Apr 03, 2024
Capivasertib: A Novel AKT Inhibitor Approved for Hormone-Receptor-Positive, HER-2-Negative Metastatic Breast Cancer.

Alexa J Luboff, David L DeRemer

|Oct 03, 2023
Unraveling Racial Disparities in Supportive Care Medication Use among End-of-Life Pancreatic Cancer Patients: Focus on Pain Management and Psychiatric Therapies.

John M Allen, MegCholack Awunti, Yi Guo

|Jun 10, 2023
Adverse Cardiovascular Events Associated With Cyclin-Dependent Kinase 4/6 Inhibitors in Patients With Metastatic Breast Cancer.

Michael G Fradley, Nam H K Nguyen, David Madnick

Pageof 2

Frequent Collaborators

3 joint publications

Thomas J George

3 joint publications

Yan Gong

2 joint publications

Brian H Ramnaraign

2 joint publications

Jiang Bian